Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-22 · accession 0001209191-21-071194 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-23 | 2021-12-22 | ADPT | Taylor Stacy L | SVP, GC | M - OptEx | $6.97 | +15.3K | 25.2K | +156% | +$107.0K |
| D | 2021-12-23 | 2021-12-22 | ADPT | Taylor Stacy L | SVP, GC | S - Sale+OE | $30.00 | -15.3K | 15.0K | -50% | -$460.1K |
| DM | 2021-12-23 | 2021-12-22 | ADPT | Taylor Stacy L | SVP, GC | M - OptEx | $0.00 | -15.3K | 5,313 | -74% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-22 | M | A | 5,208 | $7.80 | 30,374 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-22 | S | D | 15,338 | $30.00 | 15,036 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-22 | M | A | 10,130 | $6.55 | 25,166 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-12-22 | M | D | 5,208 | $0.00 | 17,709 | D | $7.80 · — to 2029-04-23 | 5,208 Common Stock | (F3) The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-12-22 | M | D | 10,130 | $0.00 | 5,313 | D | $6.55 · — to 2028-04-24 | 10,130 Common Stock | (F2) The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |